Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03077698
Title An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Xenetic Biosciences, Inc.
Indications

endometrial carcinoma

Therapies

Megestrol acetate + Sodium cridanimod

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.